Pevaz: A phase II study of pevonedistat and azacitidine in MDS and MDS/MPN patients relapsed or refractory to DNMT inhibition (DNMTI) Meeting Abstract
| Authors: | Watts, J.; Smith, B.; Bradley, T.; Skikne, B.; Mendler, J.; Klimek, V.; Thomassen, A.; Stopcyzinski, T.; Chen, S. C.; Run, F.; Anderson, I.; Moncrief, A.; Madhu, S.; Sochacki, A.; Kishtagari, A.; Strickland, S.; Byrne, M.; Ayers, G.; Mohan, S.; Moyo, T.; Savona, M. |
| Abstract Title: | Pevaz: A phase II study of pevonedistat and azacitidine in MDS and MDS/MPN patients relapsed or refractory to DNMT inhibition (DNMTI) |
| Meeting Title: | 17th International Congress on Myelodysplastic Syndromes (MDS) |
| Journal Title: | Leukemia Research |
| Volume: | 128 |
| Issue: | Suppl. |
| Meeting Dates: | 2023 May 3-6 |
| Meeting Location: | Marseille, France |
| ISSN: | 0145-2126 |
| Publisher: | Elsevier Ltd |
| Date Published: | 2023-05-01 |
| Start Page: | 107272 |
| Language: | English |
| ACCESSION: | WOS:000995928100195 |
| DOI: | 10.1016/j.leukres.2023.107272 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P137 -- Source: Wos |
